Atai Life Sciences Profit Margin 2020-2025 | ATAI

Current and historical gross margin, operating margin and net profit margin for Atai Life Sciences (ATAI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Atai Life Sciences net profit margin as of March 31, 2025 is 0%.
Atai Life Sciences Annual Profit Margins
Atai Life Sciences Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.525B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.765B 18.49
Encompass Health (EHC) United States $11.937B 25.31
DaVita (DVA) United States $10.763B 15.13
Elanco Animal Health (ELAN) United States $7.400B 15.85
Chemed (CHE) United States $6.728B 21.15
Option Care Health (OPCH) United States $4.893B 21.81
RadNet (RDNT) United States $4.163B 264.19
Amedisys (AMED) United States $3.189B 21.45
Addus HomeCare (ADUS) United States $2.041B 22.41
LifeStance Health (LFST) United States $1.754B 0.00
Astrana Health (ASTH) United States $1.396B 34.58
U.S Physical Therapy (USPH) United States $1.132B 29.22
Pennant (PNTG) United States $0.870B 31.94
Aveanna Healthcare Holdings (AVAH) United States $0.792B 45.11
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00